Evidence map›Paper›PMID 27786171›Full record

ArticleNature communications2016

Engineered AAA+ proteases reveal principles of proteolysis at the mitochondrial inner membrane.

Hui Shi, Anthony J Rampello, Steven E Glynn

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Molecular mechanisms of mitochondrial AAA+ proteases.The Journal of biological chemistry · 2026
    Review
  3. Recognition of small Tim chaperones by the mitochondrial Yme1 protease.Protein science : a publication of the Protein Society · 2026
    Article
  4. Article
  5. Review
  6. Substrate-dependent activation of LONP1 informs on proteolytic regulation and ATPase motor function.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Review
  9. FAM210A: An emerging regulator of mitochondrial homeostasis.BioEssays : news and reviews in molecular, cellular and developmental biology · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. High SPATA18 Expression and its Diagnostic and Prognostic Value in Clear Cell Renal Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  16. Review
  17. AAA+ proteins: one motor, multiple ways to work.Biochemical Society transactions · 2022
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hui ShiDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York 11794-5215, USA.ORCID http://orcid.org/0000-0002-2027-723X
Anthony J RampelloDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York 11794-5215, USA.
Steven E GlynnDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York 11794-5215, USA.
Stony Brook University · US

Funding

Using rebuilt AAA+ enzymes to uncover the mechanisms of proteolysis at the mitochondrial inner membraneR01GM115898 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GLYNN, STEVEN · 2015 to 2024
$3.0M
MOLECULAR AND CELLULAR BIOLOGY TRAINING PROGRAMT32GM008468 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI NEIMAN, AARON M · 1997 to 2016
$1.9M
NIGMS NIH HHS R01 GM115898NIGMS NIH HHS T32 GM008468
6 · The paper itself

Abstract

The human YME1L protease is a membrane-anchored AAA+ enzyme that controls proteostasis at the inner membrane and intermembrane space of mitochondria. Understanding how YME1L recognizes substrates and catalyses ATP-dependent degradation has been hampered by the presence of an insoluble transmembrane anchor that drives hexamerization of the catalytic domains to form the ATPase active sites. Here, we overcome this limitation by replacing the transmembrane domain with a soluble hexameric coiled coil to produce active YME1L hexamers that can be studied in vitro. We use these engineered proteases to reveal principles of substrate processing by YME1L. Degradation by YME1L requires substrates to present an accessible signal sequence and is not initiated simply by substrate unfolding. The protease is also capable of processively unfolding substrate proteins with substantial thermodynamic stabilities. Lastly, we show that YME1L discriminates between degradation signals by amino acid composition, implying the use of sequence-specific signals in mitochondrial proteostasis.

Indexed as

Amino Acid SequenceATPases Associated with Diverse Cellular ActivitiesBiocatalysisHumansMetalloendopeptidasesMitochondrial MembranesMitochondrial ProteinsProtein EngineeringProtein MultimerizationProtein UnfoldingProteolysisProteostasisSequence Homology, Amino AcidSubstrate SpecificityATPases Associated with Diverse Cellular ActivitiesMetalloendopeptidasesMitochondrial ProteinsYME1L1 protein, human

Identifiers

PMID27786171
PMCPMC5095350
OpenAlexW2545780796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.